EP3427815B1

EP3427815B1 - Device with layered tubular membranes for chromatography

Info

Publication number: EP3427815B1
Application number: EP18187060.1A
Authority: EP
Inventors: Dharmeshkumar M. KANANI; Navneet SIDHU; Bradley A. KACHUIK; Charles H. Honeyman
Original assignee: Merck Millipore Ltd
Current assignee: Merck Millipore Ltd
Priority date: 2011-05-17
Filing date: 2012-05-17
Publication date: 2023-12-06
Anticipated expiration: 2032-05-17
Also published as: JP2020006371A; US20180141004A1; AU2012255721A1; EP2709749A4; EP3427815A1; ES2686340T3; JP2014518765A; US9873088B2; JP6588111B2; AU2017206238B2; US10195567B2; AU2019204359B2; KR101920905B1; US10874990B2; CA2836460A1; JP6831429B2; WO2012158896A3; WO2012158896A2; JP6272755B2; EP2709749B1

Description

BACKGROUND OF THE INVENTION

Membrane-based water treatment processes were first introduced in the 1970s. Since then, membrane-based separation technologies have been utilized in a number of other industries. In the pharmaceutical and biotechnology industries, the use of preparative chromatography, direct flow filtration (DFF) and tangential flow filtration (TFF), including micro-, ultra-, nano-filtration and diafiltration are well-established methods for the separation of dissolved molecules or suspended particulates. Ultrafiltration (UF) and microfiltration (MF) membranes have become essential to separation and purification in the manufacture of biomolecules. Biomolecular manufacturing, regardless of its scale, generally employs one or more steps using filtration. The attractiveness of these membrane separations rests on several features including, for example, high separation power, and simplicity, requiring only the application of pressure differentials between the feed stream and the permeate. This simple and reliable one-stage filtering of the sample into two fractions makes membrane separation a valuable approach to separation and purification.
For optimal results, any method of fluid separation demands careful attention to filter porosity and filter area, as well as required differential pressures and selected pump rates. However, filtration devices tend to clog when used over an extended period of time and must be timely replaced. Clogging of a filtration device occurs: (1) when the membrane pores become obstructed, typically with trapped cells, particulate matter, cell debris or the like, or (2) when the feed channel becomes obstructed by solids or colloidal material and/or cell debris. This clogging of the feed channel or membrane pores results in a decreased liquid flow across the porous filter membrane. The result is a change in system pressure which, if not properly addressed, runs the risk of serious detriment to the operation which incorporates the filtration procedure.
As such, the choice of membrane in each of the filtration techniques is critical to the efficiency and success of the separation. Composite membranes with high specificity and high binding capacity have been described in US Patent No. 7,316,919 , and US Patent Application Publication Nos. 2008/0314831 , 2008/0312416 , 2009/0029438 , 2009/0032463 , 2009/0008328 , 2009/0035552 , 2010/0047551 , and 2010/0044316 .
These materials are highly versatile and can be designed for specific separation situations.
Other relevant documents are WO2010/027955 , WO98/35738 and EP1323461 .
However, upon commercialization, the use of these composite membranes in typical device configurations often led to lower than expected binding capacities for the device. Therefore, there exists a need for a device configuration that will exploit the high throughput capabilities of these membranes, without sacrificing performance or scalability.

SUMMARY OF THE INVENTION

The invention relates to a fluid treatment device as defined in claim 1.

BRIEF DESCRIPTION OF THE FIGURES

Figure 1 depicts tabulated results of protein adsorption using various wrapped elements of the invention with a strong cation exchange (S) membrane and different interleaf materials ("spacer").
Figure 2 depicts tabulated results of protein adsorption using various wrapped elements of the invention with a strong cation exchange (S) membrane and different interleaf materials ("spacer"). The protein adsorbed was lysozyme in 10 mM MES buffer at pH 5.5.
Figure 3 depicts tabulated results of protein adsorption using various wrapped elements of the invention with a strong anion exchange (Q) membrane and different interleaf materials ("spacer"). The protein adsorbed was bovine serum albumin (BSA) in 25 mM Tris buffer at pH 8.1.
Figure 4 depicts tabulated results of protein adsorption using various wrapped elements of the invention with a strong anion exchange (Q) membrane and different interleaf materials ("spacer"). The protein adsorbed was bovine serum albumin (BSA) in 25 mM Tris buffer at pH 8.1.
Figure 5 depicts tabulated results of protein adsorption using various wrapped elements of the invention with a weak cation exchange (C) membrane and different interleaf materials ("spacer").
Figure 6 depicts a summary of the membranes used in Figures 1-5; the binding capacities indicate binding capacity of the membrane when used in a normal cut-disk membrane device, not when pleated or wrapped.
Figure 7 depicts a cross-section of a fluid treatment device of the invention. The wrapped fluid treatment element is visible; the arrows indicate direction of the fluid flow through the membrane.
Figure 8 depicts inferior binding capacities of various commercially-available products with different fluid treatment elements.
Figure 9 depicts inferior binding capacities of various commercially-available products with different fluid treatment elements.
Figure 10 depicts inferior binding capacities of various commercially-available products with different fluid treatment elements.
Figure 11 depicts inferior binding capacity of a commercially-available product with a different fluid treatment element, in comparison to S and Q flat, cut-disk membrane.
Figure 12 depicts (a) an inner core; (b) the inner core being wrapped with a screen using hot melt in order to assist in uniform flow collection; and (c) the wrapped inner core material.
Figure 13 depicts (a) a membrane sheet with interleaf; (b) the membrane sheet with interleaf being wrapped around an inner core; and (c) a wrapped fluid treatment element with adhesive (silicone II* clear) applied on all the edges of membrane sheet.
Figure 14 depicts alternative views of interleaf on top of a membrane sheet.
Figure 15 depicts (a) the sealing of the whole edge of the top layer with glue to make sure no leak occurs; (b) the sealing of the ends using silicone II* clear glue; and (c) a completed exemplary wrapped fluid treatment element.
Figure 16 depicts alternative embodiments comprising multiple wrapped fluid treatment elements in one device.
Figure 17 depicts an alternative embodiment - a spiral wound fluid treatment element.
Figure 18 depicts an exemplary configuration of a spiral wound device. There are three series of concentric envelopes, wherein each envelope has a spacer material inside and three of the sides are sealed. Each envelope is separated by a feed spacer. Fluid flow is directed such that raw fluid travels on the outside of each envelope and is forced through the membrane. The permeate travels along the permeate spacer to the permeate collection pipe.
Figure 19 depicts a cross-section of an exemplary fluid treatment device of the invention.
Figure 20 depicts a comparison between a fluid treatment device of the invention (wrapped fluid treatment element, bottom row) and a capsule device (pleated membrane element); pleating the membrane causes lower than expected binding capacity, while using a wrapped membrane increases expected binding capacity.
Figure 21 is a summary of some of the properties of exemplary interleaf materials for use in the present invention.

DETAILED DESCRIPTION OF THE INVENTION

OVERVIEW

Certain macroporous cross-linked composite materials lose some level of performance upon being pleated and placed in a fluid treatment device. See Figure 20. Therefore, in certain embodiments, the invention relates to a wrapped fluid treatment element with a design that allows a macroporous cross-linked composite material to be packed inside a device without any crease or pleat. In certain embodiments, the wrapped fluid treatment element of the invention may be suitable for even brittle membranes, for example a membrane comprising Protein A functionality.
In certain embodiments, membrane stacking (or wrapping around inner core) improves the breakthrough binding capacity of the device on the membrane volume basis as most of the layers in membrane stack reach saturation binding capacity by the time last layer reach breakthrough binding capacity.
In certain embodiments, the invention relates to a device that displays superior performance in comparison to know devices. In certain embodiments, the devices may tolerate about 10X to about 100X higher throughput than resins. In certain embodiments, the devices may display up to about 25X higher binding capacity than existing chromatographic membranes and resins.
In certain embodiments, the invention relates to a device that is scalable and produces predictable results in the transitions from Lab to Pilot to Production, unlike conventional resin products. In certain embodiments, the invention relates to a device that is inexpensive and easy to manufacture.
In certain embodiments, the superior mechanical strength of the devices and the inherent hydrophilicity of the composite membranes lead to longer in-process product lifetimes and more consistent performance.
In certain embodiments, the invention relates to a device that may be available as a single use or multi-cycle disposable unit. This flexibility may eliminate costly and time-consuming cleaning and storage validation. Furthermore, the devices of the invention enable simple process and may improve regulatory compliance.
In certain embodiments, the invention relates to separation processes that may require reduced buffer usage. In certain embodiments, using devices of the present invention may eliminate the need for column cleaning, equilibration, or storage in expensive buffers. In certain embodiments, the devices of the invention may tolerate higher concentration feed stream, so no dilution may be needed.
In certain embodiments, using the devices described herein may lower capital expenses and may offer significant operational cost savings for a client. In certain embodiments, the devices of the invention may have a lower initial cost and faster delivery. In certain embodiments, the devices allow for lower staffing requirements and reduced maintenance costs.
In certain embodiments, the invention relates to a device with a small footprint. In certain embodiments, the devices of the invention exhibit higher binding capacity and require less floor space than typical resin bed chromatography devices.

DEFINITIONS

For convenience, before further description of the present invention, certain terms employed in the specification, examples and appended claims are collected here. These definitions should be read in light of the remainder of the disclosure and understood as by a person of skill in the art. Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by a person of ordinary skill in the art.
In describing the present invention, a variety of terms are used in the description. Standard terminology is widely used in filtration, fluid delivery, and general fluid processing art.
The articles "a" and "an" are used herein to refer to one or to more than one (i.e., to at least one) of the grammatical object of the article. By way of example, "an element" means one element or more than one element.
The term "associated with" as used herein in such phrases as, for example, "an inorganic metal oxide associated with an stabilizing compound," refers to the presence of either weak or strong or both interactions between molecules. For example weak interactions may include, for example, electrostatic, van der Waals, or hydrogen-bonding interactions. Stronger interactions, also referred to as being chemically bonded, refer to, for example, covalent, ionic, or coordinative bonds between two molecules. The term "associated with" also refers to a compound that may be physically intertwined within the foldings of another molecule, even when none of the above types of bonds are present. For example, an inorganic compound may be considered as being in association with a polymer by virtue of existing within the interstices of the polymer.
The terms "comprise" and "comprising" are used in the inclusive, open sense, meaning that additional elements may be included.
The term "including" is used to mean "including but not limited to." "Including" and "including but not limited to" are used interchangeably.
The term "polymer" is used to mean a large molecule formed by the union of repeating units (monomers). The term polymer also encompasses copolymers.
The term "co-polymer" is used to mean a polymer of at least two or more different monomers. A co-polymer can be comprised of a cross-linker and a monomer, if the cross-linker is a difunctional monomer.
The term "two phase fluid" is used to mean a fluid comprising a liquid phase in which either substantially solid particles are dispersed therethrough, or a first liquid phase in which droplets or particles of a second liquid phase immiscible with such first liquid phase are dispersed through such first liquid phase. A "multiphase fluid" is used to mean a fluid comprising a first liquid phase in which at least one additional second solid or liquid phase is dispersed therethrough.
The term "particle" is used to mean a discreet liquid droplet or a solid object, with a characteristic dimension such as a diameter or length of between about one nanometer, and about one-tenth of a meter.
The term "particle size" is used to mean a number-average or weight-average particle size as measured by conventional particle size measuring techniques well known to those skilled in the art, such as dynamic or static light-scattering, sedimentation field-flow fractionation, photon-correlation spectroscopy, or disk centrifugation. By "an effective average particle size of less than about 1000 nm" it is meant that at least about 90% of the particles have a number-average or weight-average particle size of less than about 1000 nm when measured by at least one of the above-noted techniques. The particular size of particles in a fluid being processed will depend upon the particular application.
The term "interstices" is used to mean a space, especially a small or narrow one, between things or parts.
The term "dispersion" is used to mean any fluid comprising a liquid phase in which substantially solid particles are suspended, and remain suspended, at least temporarily.
The term "slurry" is used to mean any fluid comprising a liquid phase in which substantially solid particles are present. Such particles may or may not be suspended in such fluid.
The term "emulsion" is used to mean any fluid comprising a first liquid phase within which droplets or particles of a substantially liquid second phase are suspended, and remain suspended, at least temporarily. In reference to discreet entities of a second liquid phase in a first liquid phase, the terms "droplets" and "particles" are used interchangeably herein.
The term "crossflow" in reference to filtration is used to mean a filtration configuration in which a flowing fluid is directed along the surface of a filter medium, and the portion of fluid that passes through such filter medium has a velocity component which is "cross-wise", i.e., perpendicular to the direction of the fluid flowing along the surface of such filter medium.
The term "tangential filtration" is used to mean a filtration process in which a flowing fluid is directed substantially parallel (i.e., tangential) to the surface of a filter medium, and a portion of fluid passes through such filter medium to provide a permeate. The terms "tangential filtration" and "crossflow filtration" are often used interchangeably in the art.
The term "permeate" is used to mean the portion of the fluid that passes through the filter medium and out through a first outlet port in the filter device that is operatively connected to such filter medium. The term "decantate" is used to mean the portion of the fluid that flows along the surface of the filter medium, but does not pass through such filter medium, and passes out through a second outlet port in the filter device that is operatively connected to such filter medium.
Crossflow filtration and tangential filtration are well known filtration processes. Reference may be had to, e.g., U.S. Pat. Nos. 5,681,464 , 6,461,513 ; 6,331,253 , 6,475,071 , 5,783,085 , 4,790,942 , Reference may also be had to "Filter and Filtration Handbook", 4th Ed., T. Christopher Dickenson, Elsevier Advanced Technology, 1997
The term "average pore diameter" of the macroporous cross-linked gel may be understood by one of ordinary skill in the art as being determined by any suitable method. For example, average pore diameter may be estimated by environmental scanning electron microscopy (ESEM) images of the surface. ESEM can be a very simple and useful technique for characterising micro filtration membranes. A clear and concise picture of the membrane can be obtained in terms of the top layer, cross-section and bottom layer; the porosity and pore size distribution can be estimated from the photographs.
Alternatively, average pore diameter of the macroporous cross-linked gel may be calculated indirectly, from the measurement of flux (Q_H2O ) through a flat cut-disk membrane. The hydrodynamic Darcy permeability, k (m²), of the membrane was calculated from the following equation $k = \frac{Q_{H_{2} O} ηδ}{3600 d_{H_{2} O} ΔP}$
where η is the water viscosity (Pa·s), δ is the membrane thickness (m), d_H2O is the water density (kg/m³), and ΔP (Pa) is the pressure difference at which the flux, Q_H2O, was measured.
The hydrodynamic Darcy permeability of the membrane was used to estimate an average hydrodynamic radius of the pores in the porous gel. The hydrodynamic radius, r_h, is defined as the ratio of the pore volume to the pore wetted surface area and can be obtained from the Carman-Kozeny equation given in the book by J. Happel and H. Brenner, Low Reynolds Number Hydrodynamics, Noordhof Int. Publ., Leyden, 1973, p. 393: $k = \frac{{εr}_{h}^{2}}{K}$
where K is the Kozeny constant and ε is the membrane porosity (or volume porosity of the composite material). It is necessary to assume a value for the Kozeny constant and for the purpose of these calculations with the inventive membranes, the inventors assume a value of 5. The porosity of the membrane was estimated from porosity of the support by subtracting the volume of the gel polymer.
Hydrodynamic radius (r_h ) is 0.5 x pore radius (r_p ); pore radius (r_p ) is 0.5 x pore diameter (pore size).
The "volume porosity" of the support member is determined by a simple calculation. For example, for a support member made with polypropylene, the external dimensions of the support member are measured, and the aggregate volume is calculated [for example, for a flat, circular disk: V = πr²h, the volume of the support member if it were solid, or not porous]. The mass of the support member is then determined. Because the density of polypropylene is known or can be determined from the Polymer Handbook, edited by Brandrup et al., Chapter VII, Wiley and Sons, New York, 1999, the volume porosity is calculated as in the following example: $volume porosity = \{(volume of support member if solid) - [(\begin{array}{l} mass of \\ support member \end{array}) / (density of polypropylene)]\} / (\begin{array}{l} volume of support \\ member if solid \end{array}) .$
In this calculation, the void volume of the support member is = (volume of external dimensions of support member) - [(mass of support member) / (density of polypropylene)]. For example, the density of polypropylene = 0.91 g/cm³.
The volume porosity of the composite material, ε, is an experimentally-determined value for each composite material. It is calculated by mass. The macroporous cross-linked gel is incorporated into the void volume of the support member. The mass of the incorporated gel is measured after drying to a constant weight. The partial specific volume of the polymer is known or can be determined from the Polymer Handbook, edited by Brandrup et al., Chapter VII, Wiley and Sons, New York, 1999. The maximum volume that the gel could occupy is the void volume of the support member (calculated as described above). The volume porosity of the gel is calculated $ε = \{(void volume of support member) - [(mass of gel) \times (\begin{array}{l} partial \\ specific volume of gel polymer \end{array})]\} / (void volume of support member)$

EXEMPLARY DEVICES

In certain embodiments, the invention relates to a fluid treatment device comprising a housing unit, wherein the housing unit comprises

(a) a first opening and a second opening;
(b) a fluid flow path between the first opening and the second opening; and
(c) a wrapped fluid treatment element comprising composite material and interleaf forming layers wrapped around an inner core.,

(a) a first opening and a second opening;
(b) a fluid flow path between the first opening and the second opening; and
(c) a wrapped fluid treatment element comprising composite material and interleaf forming layers wrapped around an inner core,

In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices, wherein the layers of composite material and interleaf are alternating layers of composite material and interleaf (that is, (composite material - interleaf)_x or (interleaf - composite material)_x). In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices, wherein the layers of composite material and interleaf are arranged (interleaf - first composite material - second composite material)_x or (first composite material - second composite material - interleaf)_x. In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices, wherein the layers of composite material and interleaf are arranged in a combination of the aforementioned arrangements. In certain embodiments, the first composite material and the second composite material are identical.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices, wherein the inner core is a cylinder; the layer immediately adjacent to the inner core is a first layer of interleaf; and the first opening or the second opening is operably connected to the first layer of interleaf.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices, wherein the inner core is a cylinder; the layer immediately adjacent to the inner core is a first layer of interleaf; and the first opening is operably connected to the first layer of interleaf.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices, wherein the inner core is a cylinder; the layer immediately adjacent to the inner core is a first layer of interleaf; the first opening is operably connected to the first layer of interleaf; and the first opening is an inlet.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices, wherein the inner core is a cylinder; the layer immediately adjacent to the inner core is a first layer of interleaf; the second opening is operably connected to the first layer of interleaf; and the second opening is an outlet.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices, wherein the inner core is operably connected to the first opening; and the first opening is an inlet.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices, wherein the inner core is operably connected to the second opening; and the second opening is an outlet.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices, wherein the fluid flow path is towards the inner core.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices, wherein the fluid flow path is away from the inner core.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices, wherein the housing unit is substantially cylindrical. In certain embodiments, the housing unit has an inner diameter of about 1 cm to about 50 cm.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices, wherein the inner diameter of the housing unit is greater than the external diameter of the wrapped fluid treatment element.
In certain embodiments, the thickness of the walls of the housing unit may be adapted to the specific operation conditions.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices, wherein the housing unit is disposable or reusable.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices, wherein the housing unit is plastic or stainless steel.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices, wherein a plurality of housing units are arranged in series.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices, comprising about 2 to about 10 housing units.
In certain embodiments, wherein the first opening or the second opening is a press fit attachment point, a luer lock attachment point, or a hose barb attachment point. In certain embodiments, the first opening is a press fit, luer lock, or hose barb attachment points. In certain embodiments, the second opening is a press fit, luer lock, or hose barb attachment points. In certain embodiments, the first opening or the second opening are different kinds of attachment points from one another. In certain embodiments, the first opening or the second opening are both press fit attachment points. In certain embodiments, the first opening or the second opening are both luer lock attachment points. In certain embodiments, the first opening or the second opening are both hose barb attachment points.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices, wherein the device can be scaled by increasing either the diameter or length of the housing unit.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices, wherein the device comprises a sensor. In certain embodiments, the sensor is a radio-frequency (RF) sensor. In certain embodiments, the device and the sensor are configured as described in US 2011/10031178
In certain embodiments, the device and sensor are configured as described in US 2011/10094951 In certain embodiments, the sensor provides information regarding temperature, pressure, pH, or conductivity of the device. In certain embodiments, the sensor provides information regarding temperature, pressure, pH, or conductivity of an internal microenvironment of the device. In certain embodiments, the communication system for the sensor can be of any type, such as a wireless RF transmitter, an infrared (IR) transmitter, an inductance coil, or a sound generator. In certain embodiments, the sensor wirelessly reports data without the need for maintaining or replacing batteries. Instead, the sensing systems rely on harvesting vibration, strain energy, or magnetic coupled energy from the local environment for conversion to electrical power for storage and use to collect, store, or transmit data by the sensing system. In certain embodiments, the sensor is powered remotely by a system as described in US Patent No. 7,901,570

EXEMPLARY WRAPPED FLUID TREATMENT ELEMENTS

In certain embodiments, the invention relates to wrapped fluid treatment elements. In certain embodiments, the wrapped fluid treatment element is for use in a fluid treatment device of the present invention.
In certain embodiments, the invention relates to a wrapped fluid treatment element comprising:

a composite material;
an interleaf; and
an inner core,

In certain embodiments, the invention relates to any one of the above-mentioned wrapped fluid treatment elements, wherein the layers of composite material and interleaf are alternating layers of composite material and interleaf (that is, (composite material - interleaf)_x or (interleaf - composite material)_x). In certain embodiments, the invention relates to any one of the above-mentioned wrapped fluid treatment elements, wherein the layers of composite material and interleaf are arranged (interleaf - first composite material - second composite material)_x or (first composite material - second composite material - interleaf)_x In certain embodiments, the invention relates to any one of the above-mentioned wrapped fluid treatment elements, wherein the layers of composite material and interleaf are arranged in a combination of the aforementioned arrangements. In certain embodiments, the first composite material and the second composite material are identical.
In certain embodiments, the invention relates to any one of the above-mentioned wrapped fluid treatment elements, wherein the layers are wrapped spirally around the inner core. In certain embodiments, the composite material is in contact with the interleaf. In certain embodiments, a first surface of the composite material is not in contact with a second surface of the composite material. In certain embodiments, the interleaf prevents the first surface of the composite material from being in contact with the second surface of the composite material.
In certain embodiments, the invention relates to any one of the above-mentioned wrapped fluid treatment elements, wherein the layers are concentric circles around the inner core. In certain embodiments, the invention relates to any one of the above-mentioned wrapped fluid treatment elements, wherein the layers are not concentric circles around the inner core.
In certain embodiments, the invention relates to any one of the above-mentioned wrapped fluid treatment elements, wherein the layer immediately adjacent to the inner core is a layer of interleaf.
In certain embodiments, the invention relates to any one of the above-mentioned wrapped fluid treatment elements, wherein the inner core is a cylinder; and the layer immediately adjacent to the inner core is a layer of interleaf.
In certain embodiments, the invention relates to any one of the above-mentioned wrapped fluid treatment elements, wherein the wrapped fluid treatment element comprises about 3 to about 50 layers of composite material around the inner core. In certain embodiments, the invention relates to any one of the above-mentioned wrapped fluid treatment elements, wherein the wrapped fluid treatment element comprises about 5 to about 35 layers of composite material around the inner core.
In certain embodiments, the invention relates to wrapped fluid treatment elements comprising membranes. In certain embodiments, the invention relates to wrapped fluid treatment elements comprising composite materials for use as membranes.
In certain embodiments, the wrapped fluid treatment elements are disposable or reusable.
In certain embodiments, the wrapped fluid treatment elements of the present invention accommodate high solid density materials. In certain embodiments, the wrapped fluid treatment elements of the present invention are used for their strength. In certain embodiments, the wrapped fluid treatment elements of the present invention are used in heavy duty applications. In certain embodiments, the wrapped fluid treatment elements of the present invention can tolerate elevated temperatures for sustained periods.
In certain embodiments, the wrapped fluid treatment elements of the present invention exhibit reduced capture time in chromatography applications. In certain embodiments, the wrapped fluid treatment elements of the present invention exhibit high binding capacities.
In certain embodiments, the packing density of the composite material may be improved by increasing the number of wraps in a wrapped fluid treatment element.
In certain embodiments, the wrapped fluid treatment elements of the invention relate to an integral membrane element. In certain embodiments, the components of the wrapped fluid treatment element are sealed while wrapping the composite material and interleaf. In certain embodiments, the components of the wrapped fluid treatment element are sealed in a post-wrapped state. In certain embodiments, the invention may related to any one of the above-mentioned wrapped fluid treatment elements, wherein the wrapped fluid treatment element further comprises a sealing end cap, wherein the sealing end cap seals the layers of wrapped composite material and interleaf. In certain embodiments, the end may be sealed by wicking a lower viscosity adhesive into the element and curing it such that a seal is formed.
In certain embodiments, the invention relates to a wrapped fluid treatment element configured as a spiral wound device. In certain embodiments, this fluid treatment element, for example, comprises two rectangular sheets of membrane (composite material), separated by one rectangular sheet of permeate spacer of a similar size as the two sheets of membrane. The membrane envelope is sealed on three sides (two long sides and one short side). The unsealed short side of the envelope is attached to the inner core, and the sealed envelope is wrapped around the inner core. By this method, permeate must only pass through one membrane layer before it travels in a spiral fashion along the permeate spacer layer to the inner core.

EXEMPLARY INTERLEAF

In certain embodiments, the presence of interleaf material between the membrane layers improves the performance of the device. In certain embodiments, the interleaf helps to reduce back-pressure. In certain embodiments, the interleaf helps to maintain binding capacity.
In certain embodiments, interleaf may be a screen or a non-woven material.
In certain embodiments, the interleaf is mesh. In certain embodiments, the interleaf is 1-mm mesh or 0.45-mm mesh.
In certain embodiments, the interleaf is a capsule spacer. In certain embodiments, a capsule spacer is made of the same material as the material used as a spacer in a pleated capsule device. In certain embodiments, the capsule spacer is UNIPRO FX (100% SB polypropylene (flat bond)) from Midwest Filtration. In certain embodiments, the interleaf is about 100 µm to about 400 µm thick. In certain embodiments, the interleaf is about 100 µm, about 150 µm, about 200 µm, about 250 µm, about 300 µm, about 350 µm, or about 400 µm thick. In certain embodiments, the interleaf is about 210 µm thick. In certain embodiments, the interleaf has about 50% to about 99% volume porosity. In certain embodiments, the interleaf has about 70% to about 95% volume porosity. In certain embodiments, the interleaf has about 70%, about 75%, about 80%, about 85%, about 90%, or about 95% volume porosity. In certain embodiments, the interleaf has from about 80% to about 90% volume porosity. In certain embodiments, the interleaf is substantially compressible.
In certain embodiments, the interleaf is a lab substrate. In certain embodiments, the interleaf is polypropylene. In certain embodiments, the interleaf is non-woven polypropylene. In certain embodiments, the interleaf is non-woven polypropylene from Hollingsworth and Vose. In certain embodiments, the interleaf is about 100 µm to about 400 µm thick. In certain embodiments, the interleaf is about 100 µm, about 150 µm, about 200 µm, about 250 µm, about 300 µm, about 350 µm, or about 400 µm thick. In certain embodiments, the interleaf is about 250 µm thick. In certain embodiments, the interleaf has about 50% to about 90% volume porosity. In certain embodiments, the interleaf has about 60% to about 85% volume porosity. In certain embodiments, the interleaf has about 65%, about 70%, about 75%, about 80%, or about 85% volume porosity. In certain embodiments, the interleaf has from about 70% to about 80% volume porosity. In certain embodiments, the interleaf is substantially compressible.
In certain embodiments, the interleaf is polyethylene. In certain embodiments, the interleaf is high-density polyethylene.
In certain embodiments, the interleaf is a lab-like substrate. In certain embodiments, the interleaf is polypropylene. In certain embodiments, the interleaf is spunbound polypropylene. In certain embodiments, the interleaf is spunbound polypropylene of basis weight of about 0.70 oz/yd² to about 0.95 oz/yd². In certain embodiments, the interleaf is spunbound polypropylene of basis weight of about 0.70 oz/yd², about 0.75 oz/yd², about 0.80 oz/yd², about 0.85 oz/yd², about 0.90 oz/yd², or about 0.95 oz/yd². In certain embodiments, the interleaf is spunbound polypropylene of basis weight about 0.86 oz/yd². In certain embodiments, the interleaf is about 50 µm to about 300 µm thick. In certain embodiments, the interleaf is about 50 µm, about 100 µm, about 150 µm, about 200 µm, about 250 µm, or about 300 µm thick. In certain embodiments, the interleaf is about 150 µm thick. In certain embodiments, the interleaf has about 50% to about 99% volume porosity. In certain embodiments, the interleaf has about 80% to about 99% volume porosity. In certain embodiments, the interleaf has about 80%, about 85%, about 90%, or about 95% volume porosity. In certain embodiments, the interleaf has from about 85% to about 99% volume porosity. In certain embodiments, the interleaf is substantially compressible.
In certain embodiments, the interleaf is a filter. In certain embodiments, the interleaf is polypropylene. In certain embodiments, the interleaf is AVSPUN 70 GSM POLYPRO, from Midwest Filtration. In certain embodiments, the interleaf is about 100 µm to about 500 µm thick. In certain embodiments, the interleaf is about 100 µm, about 150 µm, about 200 µm, about 250 µm, about 300 µm, about 350 µm, about 400 µm, about 450 µm, or about 500 µm thick. In certain embodiments, the interleaf is about 365 µm thick. In certain embodiments, the interleaf has about 50% to about 90% volume porosity. In certain embodiments, the interleaf has about 65% to about 90% volume porosity. In certain embodiments, the interleaf has about 65%, about 70%, about 75%, about 80%, about 85%, about 90%, or about 95% volume porosity. In certain embodiments, the interleaf has from about 75% to about 85% volume porosity. In certain embodiments, the interleaf is substantially compressible.
In certain embodiments, the interleaf is mesh. In certain embodiments, the mesh interleaf is extruded netting. In certain embodiments, the mesh interleaf is about 0.45-mm mesh. In certain embodiments, the mesh interleaf is a biplanar thermoplastic netting. In certain embodiments, the mesh interleaf is substantially similar to Naltex (a particular biplanar thermoplastic netting), from DelStar Technologies, Inc. In certain embodiments, the interleaf is about 300 µm to about 600 µm thick. In certain embodiments, the interleaf is about 300 µm, about 350 µm, about 400 µm, about 450 µm, about 500 µm, about 550 µm, or about 600 µm thick. In certain embodiments, the interleaf is about 450 µm thick. In certain embodiments, the interleaf has about 90% to about 99% volume porosity. In certain embodiments, the interleaf has about 90%, about 91%, about 92%, about 93%, about 94%, about 95%, about 96%, about 97%, about 98%, or about 99% volume porosity. In certain embodiments, the interleaf has from about 97% to about 99% volume porosity. In certain embodiments, the interleaf is substantially non-compressible.
In certain embodiments, the interleaf is mesh. In certain embodiments, the mesh interleaf is extruded netting. In certain embodiments, the mesh interleaf is about 0.45-mm mesh. In certain embodiments, the mesh interleaf is a biplanar thermoplastic netting. In certain embodiments, the mesh interleaf is substantially similar to Naltex, from DelStar Technologies, Inc. In certain embodiments, the interleaf is about 800 µm to about 1200 µm thick. In certain embodiments, the interleaf is about 800 µm, about 850 µm, about 900 µm, about 950 µm, about 1000 µm, about 1050 µm, about 1100 µm, about 1150 µm, or about 1200 µm thick. In certain embodiments, the interleaf is about 1000 µm thick. In certain embodiments, the interleaf has about 90% to about 99% volume porosity. In certain embodiments, the interleaf has about 90%, about 91%, about 92%, about 93%, about 94%, about 95%, about 96%, about 97%, about 98%, or about 99% volume porosity. In certain embodiments, the interleaf has from about 97% to about 99% volume porosity. In certain embodiments, the interleaf is substantially non-compressible.
In certain embodiments, the interleaf is paper. In certain embodiments, the interleaf is unbound glass. In certain embodiments, the interleaf is cellulose. In certain embodiments, the interleaf is about 20 µm to about 400 µm thick. In certain embodiments, the interleaf is about 20 µm, about 40 µm, about 60 µm, about 80 µm, about 100 µm, about 150 µm, about 200 µm, about 250 µm, about 300 µm, about 350 µm, or about 400 µm thick. In certain embodiments, the interleaf has about 40% to about 90% volume porosity. In certain embodiments, the interleaf has about 45% to about 85% volume porosity. In certain embodiments, the interleaf has about 45%, about 50%, about 55%, about 60%, about 65%, about 70%, about 75%, about 80%, or about 85% volume porosity. In certain embodiments, the interleaf has from about 50% to about 80% volume porosity. In certain embodiments, the interleaf is substantially compressible.
In certain embodiments, the thickness of interleaf may be increased by merely increasing the number of interleaf layers.
In certain embodiments, interleaf properties such as compressibility, percentage of openness, etc. have significant effect on the performance of the fluid treatment device.

EXEMPLARY INNER CORE

In certain embodiments, the invention relates to any one of the above-mentioned wrapped fluid treatment elements, wherein the composite material and the interleaf is wrapped around an inner core.
In certain embodiments, the inner core provides support to the wrapped fluid treatment element. In certain embodiments, the inner core provides a flow channel for a fluid.
In certain embodiments, the inner core is a cylinder. In certain embodiments, the inner core is a cylindrical pipe. In certain embodiments, the inner core is a solid cylinder.
In certain embodiments, the inner core is a cylindrical pipe. In certain embodiments, the inner core is a cylinder; and the cylinder comprises grooves or channels on its surface.
In certain embodiments, the inner core is a cylindrical pipe. In certain embodiments, the inner core is a cylinder; and the cylinder is machined.
In certain embodiments, the inner core is a cylindrical pipe. In certain embodiments, the inner core is a cylinder that is capped or sealed at both of its ends.
In certain embodiments, the inner core is a cylindrical pipe. In certain embodiments, the inner core is a perforated cylindrical pipe. In certain embodiments, the inner core is a perforated cylindrical pipe that is capped or sealed at one of its ends.
In certain embodiments, the inner core is plastic. In certain embodiments, the inner core is polypropylene.
In certain embodiments, the inner core is plastic. In certain embodiments, the inner core is polysulfone.
In certain embodiments, the material comprising the inner core may be inherently porous. In certain embodiments, the inner core is POREX.
In certain embodiments, the material comprising the inner core is not inherently porous, but holes may be mechanically made in the non-porous inner core. In certain embodiments, holes are made in the inner core by drilling. In certain embodiments, a flow channel may be made by machining.
In certain embodiments, the inner core is a screen wrapped around a pipe. In certain embodiments, the screen provides a method by which fluid may flow.
In certain embodiments, the diameter of the inner core is about 0.2 cm to about 200 cm. In certain embodiments, the diameter of the inner core is about 0.2 cm, about 0.4 cm, about 0.5 cm, about 0.6 cm, about 0.8 cm, about 1 cm, about 2 cm, about 3 cm, about 4 cm, about 5 cm, about 10 cm, about 20 cm, about 30 cm, about 40 cm, about 50 cm, about 75 cm, about 100 cm, about 125 cm, about 150 cm, or about 175 cm.
In certain embodiments, the length of the inner core is about 2 cm to about 200 cm. In certain embodiments, the length of the inner core is about 2 cm, about 3 cm, about 4 cm, about 5 cm, about 10 cm, about 20 cm, about 30 cm, about 40 cm, about 50 cm, about 75 cm, about 100 cm, about 125 cm, about 150 cm, or about 175 cm.
In certain embodiments, the inner core is a perforated cylindrical pipe, wherein the perforations are slots or holes.
In certain embodiments, the inner core comprises a highly porous cell structure like material. In certain embodiments, the inner core comprises interleaf wrapped upon itself.
In certain embodiments, the inner core is wrapped with a screen.
In certain embodiments, the inner core is a perforated rectangular prism, a perforated triangular prism, or a perforated square prism. In certain embodiments, the inner core is a perforated rectangular prism, a perforated triangular prism, or a perforated square prism, wherein the perforated rectangular prism, the perforated triangular prism, or the perforated square prism is capped or sealed at one end.

EXEMPLARY COMPOSITE MATERIALS

In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements comprising a composite material. In certain embodiments, the invention comprises a composite material for use as a membrane.
In certain embodiments, the composite materials used as membranes in the present invention are described in US Patent No. 7,316,919 ; and US Patent Application Serial Nos. 11/950,562 , 12/108,178 , 12/244,940 , 12/250,861 , 12/211,618 , and 12/250,869 ;
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises

a support member comprising a plurality of pores extending through the support member; and
a non-self-supporting macroporous cross-linked gel comprising macropores having an average diameter of 10 nm to 3000 nm, said macroporous gel being located in the pores of the support member;
wherein said macropores of said macroporous cross-linked gel are smaller than said pores of said support member.

In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the macroporous crosslinked gel of the composite material has macropores of average diameter between about 25 nm and about 1500 nm. In certain embodiments, the macroporous crosslinked gel has macropores of average diameter between about 50 nm and about 1000 nm. In certain embodiments, the macroporous crosslinked gel has macropores of average diameter of about 700 nm. In certain embodiments, the macroporous crosslinked gel has macropores of average diameter of about 300 nm.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the macroporous cross-linked gel of the composite material is a hydrogel, a polyelectrolyte gel, a hydrophobic gel, a neutral gel, or a gel comprising functional groups. In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the macroporous cross-linked gel of the composite material is a neutral or charged hydrogel; and the neutral or charged hydrogel is selected from the group consisting of cross-linked poly(vinyl alcohol), poly(acrylamide), poly(isopropylacrylamide), poly(vinylpyrrolidone), poly(hydroxymethyl acrylate), poly(ethylene oxide), copolymers of acrylic acid or methacrylic acid with acrylamide, isopropylacrylamide, or vinylpyrrolidone, copolymers of acrylamide-2-methyl-1-propanesulfonic acid with acrylamide, isopropylacrylamide, or vinylpyrrolidone, copolymers of (3-acrylamido-propyl) trimethylammonium chloride with acrylamide, isopropylacrylamide, or N-vinyl-pyrrolidone, and copolymers of diallyldimethylammonium chloride with acrylamide, isopropylacrylamide, or vinylpyrrolidone. In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the macroporous cross-linked gel of the composite material is a polyelectrolyte gel; and the polyelectrolyte gel is selected from the group consisting of cross-linked poly(acrylamido-2-methyl-1-propanesulfonic acid) and its salts, poly(acrylic acid) and its salts, poly(methacrylic acid) and its salts, poly(styrenesulfonic acid) and its salts, poly(vinylsulfonic acid) and its salts, poly(alginic acid) and its salts, poly[(3-acrylamidopropyl)trimethylammonium] salts, poly(diallyldimethylammonium) salts, poly(4-vinyl-N-methylpyridinium) salts, poly(vinylbenzyl-N-trimethylammonium) salts, and poly(ethyleneimine) and its salts. In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the macroporous cross-linked gel of the composite material is a hydrophobic gel; and the hydrophobic gel is selected from the group consisting of cross-linked polymers or copolymers of ethyl acrylate, n-butyl acrylate, propyl acrylate, octyl acrylate, dodecyl acrylate, octadecylacrylamide, stearyl acrylate, and styrene. In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the macroporous cross-linked gel of the composite material is a neutral gel; and the neutral gel is selected from the group consisting of cross-linked polymers or copolymers of acrylamide, N,N-dimethylacrylamide, N-methacryloylacrylamide, N-methyl-N-vinylacetamide, and N-vinylpyrrolidone.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the macroporous cross-linked gel of the composite material is a gel comprising functional groups. In certain embodiments, the macroporous cross-linked gel of the composite material comprises monomers, wherein the monomers comprise functional groups. In certain embodiments, the functional groups are thiols or protected thiols. In certain embodiments, the macroporous cross-linked gel comprises monomers, wherein the monomers are selected from the group consisting of allyl 3-mercaptopropionate thioacetate, (S-benzoyl-3-mercapto-2-hydroxypropyl)-2-methyl-2-propenoate, (S-2,2-dimethylpropanoyl-3-mercapto-2-hydroxypropyl)-2-methyl-2-propenoate , (S-acetyl-3-mercapto-2-acetylpropyl)-2-methyl-2-propenoate, (S-acetyl-3-mercapto-2-hydroxypropyl)-2-methyl-2-propenoate, (S-acetyl-3-mercapto-2-acetoacetylpropyl)-2-methyl-2-propenoate, (S-acetyl-3-mercapto-2-tetrahydropyranyl)-2-methyl-2-propenoate, (S-acetyl-3-mercapto-2-(2-methoxy-2-propoxy))-2-methyl-2-propenoate, (S-acetyl-2-mercapto-3-acetylpropyl)-2-methyl-2-propenoate, S-acetyl-(1-allyloxy-3-mercapto-2-hydroxypropane), S-benzoyl-(1-allyloxy-3-mercapto-2-hydroxypropane) and S-2,2-dimethylpropanoyl-(1-allyloxy-3-mercapto-2-hydroxypropane).
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises functional groups; and the functional groups are selected from the group consisting of amino acid ligands, antigen and antibody ligands, dye ligands, biological molecules, biological ions, and metal affinity ligands.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises functional groups; and said functional groups are metal affinity ligands. In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises functional groups; said functional groups are metal affinity ligands; and a plurality of metal ions are complexed to a plurality of said metal affinity ligands.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands; and said metal affinity ligands are polydentate ligands.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands; and said metal affinity ligands are octadentate, hexadentate, tetradentate, tridentate or bidentate ligands.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands; and said metal affinity ligands are tetradentate ligands.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands; and said metal affinity ligands are tridentate ligands.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands; and said metal affinity ligands are bidentate ligands.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands; and said metal affinity ligands are iminodicarboxylic acid ligands.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands; and said metal affinity ligands are iminodiacetic acid ligands.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands; and said metal affinity ligands are salts of iminodiacetic acid ligands.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands; and said metal affinity ligands are sodium salts of iminodiacetic acid ligands.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands; and said metal affinity ligands are potassium salts of iminodiacetic acid ligands.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands; and said metal affinity ligands comprise ethylenediamine moieties.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands; and said metal affinity ligands comprise hexamethylenediamine moieties.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands; and said metal affinity ligands comprise diethanolamine moieties.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands; and said metal affinity ligands comprise pentaethylenehexamine moieties.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands; and said metal affinity ligands comprise triethylenetetramine moieties.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands; and said metal affinity ligands comprise tris(carboxymethyl)ethylene diamine.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands; and said metal affinity ligands comprise conjugate bases of carboxylic acids. In certain embodiments, the conjugate bases are available as salts. In certain embodiments, the conjugate bases are available as sodium salts or potassium salts. In certain embodiments, the conjugate bases are available as sodium salts. In certain embodiments, the conjugate bases are available as potassium salts.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands complexed to a plurality of metal ions; and said metal ions are transition metal ions, lanthanide ions, poor metal ions or alkaline earth metal ions.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands complexed to a plurality of metal ions; and said metal ions are selected from the group consisting of nickel, zirconium, lanthanum, cerium, manganese, titanium, cobalt, iron, copper, zinc, silver, gallium, platinum, palladium, lead, mercury, cadmium and gold.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands complexed to a plurality of metal ions; and said metal ions are nickel or zirconium.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands complexed to a plurality of metal ions; and said metal ions are nickel.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands complexed to a plurality of metal ions; and said metal ions are zirconium.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands complexed to a plurality of metal ions; said metal affinity ligands are octadentate, hexadentate, tetradentate, tridentate or bidentate ligands; and said metal ions are transition metal ions, lanthanide ions, poor metal ions or alkaline earth metal ions.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands complexed to a plurality of metal ions; said metal affinity ligands are octadentate, hexadentate, tetradentate, tridentate or bidentate ligands; and said metal ions are selected from the group consisting of nickel, zirconium, lanthanum, cerium, manganese, titanium, cobalt, iron, copper, zinc, silver, gallium, platinum, palladium, lead, mercury, cadmium and gold.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands complexed to a plurality of metal ions; said metal affinity ligands are octadentate, hexadentate, tetradentate, tridentate or bidentate ligands; and said metal ions are nickel or zirconium.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands complexed to a plurality of metal ions; said metal affinity ligands are octadentate, hexadentate, tetradentate, tridentate or bidentate ligands; and said metal ions are nickel.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands complexed to a plurality of metal ions; said metal affinity ligands are octadentate, hexadentate, tetradentate, tridentate or bidentate ligands; and said metal ions are zirconium.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands complexed to a plurality of metal ions; said metal affinity ligands are tetradentate ligands; and said metal ions are transition metal ions, lanthanide ions, poor metal ions or alkaline earth metal ions.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands complexed to a plurality of metal ions; said metal affinity ligands are tetradentate ligands; and said metal ions are selected from the group consisting of nickel, zirconium, lanthanum, cerium, manganese, titanium, cobalt, iron, copper, zinc, silver, gallium, platinum, palladium, lead, mercury, cadmium and gold.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands complexed to a plurality of metal ions; said metal affinity ligands are tetradentate ligands; and said metal ions are nickel or zirconium.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands complexed to a plurality of metal ions; said metal affinity ligands are tetradentate ligands; and said metal ions are nickel.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands complexed to a plurality of metal ions; said metal affinity ligands are tetradentate ligands; and said metal ions are zirconium.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands complexed to a plurality of metal ions; said metal affinity ligands are tridentate ligands; and said metal ions are transition metal ions, lanthanide ions, poor metal ions or alkaline earth metal ions.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands complexed to a plurality of metal ions; said metal affinity ligands are tridentate ligands; and said metal ions are selected from the group consisting of nickel, zirconium, lanthanum, cerium, manganese, titanium, cobalt, iron, copper, zinc, silver, gallium, platinum, palladium, lead, mercury, cadmium and gold.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands complexed to a plurality of metal ions; said metal affinity ligands are tridentate ligands; and said metal ions are nickel or zirconium.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands complexed to a plurality of metal ions; said metal affinity ligands are tridentate ligands; and said metal ions are nickel.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands complexed to a plurality of metal ions; said metal affinity ligands are tridentate ligands; and said metal ions are zirconium.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands complexed to a plurality of metal ions; said metal affinity ligands are bidentate ligands; and said metal ions are transition metal ions, lanthanide ions, poor metal ions or alkaline earth metal ions.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands complexed to a plurality of metal ions; said metal affinity ligands are bidentate ligands; and said metal ions are selected from the group consisting of nickel, zirconium, lanthanum, cerium, manganese, titanium, cobalt, iron, copper, zinc, silver, gallium, platinum, palladium, lead, mercury, cadmium and gold.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands complexed to a plurality of metal ions; said metal affinity ligands are bidentate ligands; and said metal ions are nickel or zirconium.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands complexed to a plurality of metal ions; said metal affinity ligands are bidentate ligands; and said metal ions are nickel.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands complexed to a plurality of metal ions; said metal affinity ligands are bidentate ligands; and said metal ions are zirconium.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands complexed to a plurality of metal ions; said metal affinity ligands are iminodicarboxylic acid ligands; and said metal ions are transition metal ions, lanthanide ions, poor metal ions or alkaline earth metal ions.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands complexed to a plurality of metal ions; said metal affinity ligands are iminodicarboxylic acid ligands; and said metal ions are selected from the group consisting of nickel, zirconium, lanthanum, cerium, manganese, titanium, cobalt, iron, copper, zinc, silver, gallium, platinum, palladium, lead, mercury, cadmium and gold.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands complexed to a plurality of metal ions; said metal affinity ligands are iminodicarboxylic acid ligands; and said metal ions are nickel or zirconium.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands complexed to a plurality of metal ions; said metal affinity ligands are iminodicarboxylic acid ligands; and said metal ions are nickel.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands complexed to a plurality of metal ions; said metal affinity ligands are iminodicarboxylic acid ligands; and said metal ions are zirconium.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands complexed to a plurality of metal ions; said metal affinity ligands are iminodiacetic acid ligands; and said metal ions are transition metal ions, lanthanide ions, poor metal ions or alkaline earth metal ions.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands complexed to a plurality of metal ions; said metal affinity ligands are iminodiacetic acid ligands; and said metal ions are selected from the group consisting of nickel, zirconium, lanthanum, cerium, manganese, titanium, cobalt, iron, copper, zinc, silver, gallium, platinum, palladium, lead, mercury, cadmium and gold.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands complexed to a plurality of metal ions; said metal affinity ligands are iminodiacetic acid ligands; and said metal ions are nickel or zirconium.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands complexed to a plurality of metal ions; said metal affinity ligands are iminodiacetic acid ligands; and said metal ions are nickel.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises metal affinity ligands complexed to a plurality of metal ions; said metal affinity ligands are iminodiacetic acid ligands; and said metal ions are zirconium.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises functional groups; and the functional groups are biological molecules or biological ions. In certain embodiments, the biological molecules or biological ions are selected from the group consisting of albumins, lysozyme, viruses, cells, γ-globulins of human and animal origins, immunoglobulins of both human and animal origins, proteins of recombinant or natural origin including, polypeptides of synthetic or natural origin, interleukin-2 and its receptor, enzymes, monoclonal antibodies, antigens, lectins, bacterial immunoglobulin-binding proteins, trypsin and its inhibitor, cytochrome C, myoglobulin, recombinant human interleukin, recombinant fusion protein, Protein A, Protein G, Protein L, Peptide H, nucleic acid derived products, DNA of either synthetic or natural origin, and RNA of either synthetic or natural origin.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material comprises Protein A. Protein A is a 40-60 kDa MSCRAMM surface protein originally found in the cell wall of the bacteria Staphylococcus aureus. It is encoded by the spa gene and its regulation is controlled by DNA topology, cellular osmolarity, and a two-component system called ArlS-ArlR. It has found use in biochemical research because of its ability to bind immunoglobulins. It binds proteins from many of mammalian species, most notably IgGs. It binds with the Fc region of immunoglobulins through interaction with the heavy chain. The result of this type of interaction is that, in serum, the bacteria will bind IgG molecules in the wrong orientation (in relation to normal antibody function) on their surface which disrupts opsonization and phagocytosis. It binds with high affinity to human IgG1 and IgG2 as well as mouse IgG2a and IgG2b. Protein A binds with moderate affinity to human IgM, IgA and IgE as well as to mouse IgG3 and IgG1. It does not react with human IgG3 or IgD, nor will it react to mouse IgM, IgA or IgE.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the macroporous crosslinked gel of the composite material comprises a macromonomer. In certain embodiments, the macromonomer is selected from the group consisting of poly(ethylene glycol) acrylate and poly(ethylene glycol) methacrylate.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the macroporous cross-linked gel of the composite material is cross-linked by N,N-methylenebisacrylamide or a polyfunctional macromonomer. In certain embodiments, the macroporous cross-linked gel of the composite material is cross-linked by a polyfunctional macromonomer; and the polyfunctional macromonomer is selected from the group consisting of poly(ethylene glycol) diacrylate and poly(ethylene glycol) dimethacrylate. In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or elements, wherein the macroporous cross-linked gel of the composite material is cross-linked by N,N-methylenebisacrylamide.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the macroporous cross-linked gel of the composite material is a positively charged hydrogel comprising a co-polymer of (3-acrylamidopropyl)trimethylammonium chloride (APTAC) and N-(hydroxymethyl)acrylamide cross-linked by N,N'-methylenebisacrylamide.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material is a membrane; and the macroporous cross-linked gel bears charged moieties.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the composite material is a membrane for use as a filter in size exclusion separation.
In certain embodiments, the fluid treatment devices or wrapped fluid treatment elements of the invention comprise any one of the above-mentioned composite materials, wherein the composite materials comprise negatively-charged moieties. Negatively-charged membranes repel foulants at the membrane surface resulting in higher flux, easier cleanings, and lower system costs.
In certain embodiments, the fluid treatment devices or wrapped fluid treatment elements of the invention comprise any one of the above-mentioned composite materials, wherein the composite materials are hydrophilic in nature. Foulants are typically hydrophobic species.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the support member of the composite material consists essentially of polymeric material in the form of a membrane that has a thickness of about 10 µm to about 500 µm and comprises pores of average diameter of about 0.1 to about 25 µm.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the support member of the composite material consists essentially of a polyolefin.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the support member of the composite material comprises a polymeric material selected from the group consisting of polysulfones, polyethersulfones, polyphenyleneoxides, polycarbonates, polyesters, cellulose and cellulose derivatives.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the support member of the composite material consists essentially of polymeric material in the form of a fibrous fabric that has a thickness of about 10 µm to about 2000 µm and comprises pores of average diameter of about 0.1 to about 25 µm.
In certain embodiments, the invention relates to any one of the above-mentioned fluid treatment devices or wrapped fluid treatment elements, wherein the support member of the composite material comprises a stack of 2 to 10 separate support members.

EXEMPLARY METHODS

In certain embodiments, the invention relates to a method comprising the step of:

contacting a first fluid comprising a substance with a composite material in any one of the above-mentioned wrapped fluid treatment elements, thereby adsorbing or
absorbing the substance onto the composite material.

In certain embodiments, the invention relates to any one of the above-mentioned methods, further comprising the step of
placing the first fluid in a first opening of a fluid treatment device.
In certain embodiments, the invention relates to any one of the above-mentioned methods, further comprising the step of
contacting a second fluid with the substance adsorbed or absorbed onto the composite material, thereby releasing the substance from the composite material.
In certain embodiments, the invention relates to any one of the above-mentioned methods, wherein the substance is separated based on size exclusion.
In certain embodiments, the invention relates to any one of the above-mentioned methods, wherein the macroporous gel displays a specific interaction for the substance.
In certain embodiments, the invention relates to any one of the above-mentioned methods, wherein the specific interactions are electrostatic interactions, affinity interactions, or hydrophobic interactions.
In certain embodiments, the invention relates to any one of the above-mentioned methods, wherein the specific interactions are electrostatic interactions, the composite material bears charges on the macroporous gel; the substance is charged; and the substance is separated based on Donnan exclusion.
In certain embodiments, the invention relates to any one of the above-mentioned methods, wherein the first fluid is a suspension of cells or a suspension of aggregates.
In certain embodiments, the invention relates to any one of the above-mentioned methods, wherein the substance is a biological molecule or biological ion.
In certain embodiments, the invention relates to any one of the above-mentioned methods, wherein the biological molecule or biological ion is selected from the group consisting of albumins, lysozyme, viruses, cells, γ-globulins of human and animal origins, immunoglobulins of both human and animal origins, proteins of recombinant or natural origin including, polypeptides of synthetic or natural origin, interleukin-2 and its receptor, enzymes, monoclonal antibodies, trypsin and its inhibitor, cytochrome C, myoglobulin, recombinant human interleukin, recombinant fusion protein, nucleic acid derived products, DNA of either synthetic or natural origin, and RNA of either synthetic or natural origin.
In certain embodiments, the invention relates to any one of the above-mentioned methods, wherein the biological molecule or biological ion is a protein; and the protein comprises exposed amino acid residues selected from the group consisting of Glu, Asp, Try, Arg, Lys, Met, and His.
In certain embodiments, the invention relates to any one of the above-mentioned methods, wherein the biological molecule or biological ion is a protein; and the protein comprises exposed His amino acid residues.
In certain embodiments, the invention relates to any one of the above-mentioned methods, wherein the biological molecule or biological ion is a monoclonal antibody.
In certain embodiments, the invention relates to any one of the above-mentioned methods, wherein the substance is a metal-containing particle, or a metal-containing ion.
In certain embodiments, the invention relates to any one of the above-mentioned methods, wherein the metal-containing particle or metal-containing ion comprises a transition metal, a lanthanide, a poor metal, or an alkaline earth metal.
In certain embodiments, the invention relates to any one of the above-mentioned methods, wherein the metal-containing particle or metal-containing ion comprises a metal selected from the group consisting of nickel, zirconium, lanthanum, cerium, manganese, titanium, cobalt, iron, copper, zinc, silver, gallium, platinum, palladium, lead, mercury, cadmium and gold.
In certain embodiments, the invention relates to any one of the above-mentioned methods, wherein the first fluid is waste water.
In certain embodiments, the invention relates to any one of the above-mentioned methods, wherein the first fluid is waste water from ore refining, or seawater.
In certain embodiments, the invention relates to any one of the above-mentioned methods, wherein the substance is lead or mercury.
In certain embodiments, the invention relates to any one of the above-mentioned methods, wherein the substance is platinum, palladium, copper, gold, or silver.
In certain embodiments, the invention relates to any one of the above-mentioned methods, wherein the fluid is waste water; and the metal-containing particle or metal-containing ion comprises lead or mercury.
In certain embodiments, the invention relates to any one of the above-mentioned methods, wherein the first fluid is waste water from ore refining; and the metal-containing particle or metal-containing ion comprises lead or mercury.
In certain embodiments, the invention relates to any one of the above-mentioned methods, wherein the first fluid is seawater; and the metal-containing particle or metal-containing ion comprises platinum, palladium, copper, gold, or silver.
In certain embodiments, the invention relates to any one of the above-mentioned methods, wherein the first fluid comprises egg white.
In certain embodiments, the invention relates to any one of the above-mentioned methods, wherein the first fluid comprises egg white; and the substance is lysozyme.
In certain embodiments, the invention relates to a method in which, in tangential flow separation mode, no pre-processing of the raw reaction mixtures is required due to the high specificity of the composite materials in the devices of the present invention. In certain embodiments, the invention relates to a method in which separations can be carried out on a large scale. In certain embodiments, the invention relates to a method in which separations can be carried out in a shorter amount of time. In certain embodiments, the invention relates to a method in which the devices have a high binding capacity.
In certain embodiments, the invention relates to a method that comprises two steps - collecting the desired substance onto the composite material and harvesting the desired substance from the composite material.
In certain embodiments, the invention relates to a method of separating a substance from a fluid, comprising the step of:
placing the fluid in contact with a composite material in any one of the above-mentioned wrapped fluid treatment elements, thereby adsorbing or absorbing the substance to the composite material.
In certain embodiments, the invention relates to a method of separating a substance from a fluid, comprising the step of:

placing the fluid in a first opening of any one of the above-mentioned fluid treatment devices, thereby adsorbing or absorbing the substance to the composite material and producing a permeate; and
collecting the permeate from a second opening of the fluid treatment device.

In certain embodiments, the invention relates to the above-mentioned method, wherein the fluid is passed through the macropores of the composite material; and the substance is adsorbed or absorbed within the macropores of the composite material.
In certain embodiments, the invention relates to a method of separating a substance from a fluid, comprising the step of:

placing the fluid in a first opening of any one of the above-mentioned fluid treatment devices, thereby adsorbing or absorbing the substance to the composite material;
collecting the permeate from a second opening of the fluid treatment device;
placing a second fluid in the first opening of the fluid treatment device, thereby releasing the substance from the composite material.

In certain embodiments, the invention relates to the above-mentioned method, wherein the fluid is passed through the macropores of the composite material; the substance is adsorbed or absorbed within the macropores of the composite material; and the second fluid is passed through the macropores of the composite material, thereby releasing the substance from the composite material.
In certain embodiments, the invention relates to any one of the above-mentioned methods, wherein the substance is radioactive.

EXEMPLIFICATION

The invention now being generally described, it will be more readily understood by reference to the following examples, which are included merely for purposes of illustration of certain aspects and embodiments of the present invention, and are not intended to limit the invention.

EXAMPLE 1

The results comparing a 4-layer wrapped device with a 2.5" pleated membrane device are shown in Figure 20. These results have been reproduced a number times using S (strong cation exchange) and Q (strong anion exchange) membranes.

EXAMPLE 2

Fluid flow path provided control:

for breakthrough characteristics (thinner interleaf, more layers, or larger core = sharper break through)
for back pressure characteristics (thinner interleaf, more layers, or larger core = higher back pressure)
for cycling capabilities (flow into the inner core = increased back pressure; flow from the inner core radially outwards = stable back pressure, thus cycling capable)

(Device volume membrane volume) ratio increased control:

to improve process throughput (relatively more membrane = fewer cycles to process a fixed quantity; fewer cycles = less time = increased throughput)
to higher elution titer (reduction of hold-up volume = reduction of device volume = increased titer)
to decreased buffer usage (reduction of hold-up volume = decreased mixing and dilution = optimized use of buffers)

EQUIVALENTS

Those skilled in the art will recognize, or be able to ascertain using no more than routine experimentation, many equivalents to the specific embodiments of the invention described herein. Such equivalents are encompassed by the following claims.

Claims

A fluid treatment device comprising a housing unit, wherein the housing unit comprises:
(a) a first opening and a second opening;

(b) a fluid flow path between the first opening and the second opening; and

(c) a wrapped fluid treatment element comprising composite material and an interleaf forming layers wrapped around an inner core,
wherein
the composite material comprises
a support member comprising a plurality of pores extending through the support member; and

a non-self-supporting macroporous cross-linked gel comprising macropores having an average diameter of 10 nm to 3000 nm, said macroporous cross-linked gel being located in the pores of the support member,

said macropores of said macroporous cross-linked gel are smaller than said pores of said support member;

the inner core is operably connected to the first opening;

the first opening is an inlet; and

the wrapped fluid treatment element is oriented across the fluid flow path such that any fluid entering the first opening must flow through about 3 to about 50 layers of the composite material and the interleaf before exiting the second opening.
The fluid treatment device of claim 1, having a feature selected from A), B) and C):
A) the layers are wrapped spirally around the inner core;

B) the layers are concentric circles around the inner core; and

C) the layers are not concentric circles around the inner core.
The fluid treatment device of claim 1, wherein the inner core is a cylindrical pipe;
optionally wherein the inner core is a perforated cylindrical pipe; and

further optionally wherein the inner core is a perforated cylindrical pipe that is capped or sealed at one of its ends.
The fluid treatment device of any preceding claim, wherein the inner core has one or more features selected from A), B), C), D), and E):
A) the inner core is plastic; optionally wherein the inner core is polypropylene;

B) the inner core is a screen wrapped around a pipe;

C) the diameter of the inner core is about 0.2 cm to about 200 cm;

D) the length of the inner core is about 2 cm to about 200 cm; and

E) the inner core comprises interleaf wrapped upon itself.
The fluid treatment device of claim 1, wherein the housing unit has one or more features selected from A), B) and C):
A) the housing unit is substantially cylindrical; optionally wherein the housing unit has an inner diameter of about 1 cm to about 50 cm;

B) the housing unit is disposable or reusable; and

C) the housing unit is plastic or stainless steel.
The fluid treatment device of claim 1 or 5, wherein the device comprises a sensor.
The fluid treatment device of claim 1 or 2, wherein the wrapped fluid treatment element comprises composite materials for use as a membrane.
The fluid treatment device of claim 7, wherein the membrane is for use in size exclusion separation.
The fluid treatment device of any preceding claim, wherein the composite material comprises functional groups; and the functional groups are biological molecules or biological ions.
The fluid treatment device of claim 9, wherein the biological molecules or biological ions are selected from the group consisting of albumins, lysozyme, viruses, cells, γ-globulins of human and animal origins, immunoglobulins of both human and animal origins, proteins of recombinant or natural origin including, polypeptides of synthetic or natural origin, interleukin-2 and its receptor, enzymes, monoclonal antibodies, antigens, lectins, bacterial immunoglobulin-binding proteins, trypsin and its inhibitor, cytochrome C, myoglobulin, recombinant human interleukin, recombinant fusion protein, Protein A, Protein G, Protein L, Peptide H, nucleic acid derived products, DNA of either synthetic or natural origin, and RNA of either synthetic or natural origin.
The fluid treatment device of any preceding claim, wherein the composite material comprises Protein A.